Home » Stocks » ADYX

Adynxx, Inc. (ADYX)

Stock Price: $0.236 USD 0.114 (92.50%)
Updated December 4, 3:44 PM EST - Market closed

ADYX Stock Price Chart

Key Info

Market Cap 1.37M
Revenue (ttm) 589,000
Net Income (ttm) -8.73M
Shares Out 5.81M
EPS (ttm) -1.82
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 4
Last Price $0.236
Previous Close $0.123
Change ($) 0.114
Change (%) 92.50%
Day's Open 5.880
Day's Range 0.124 - 0.236
Day's Volume 763
52-Week Range 0.000 - 0.236

ADYX Stock News

There are no news available yet.

About ADYX

Adynxx, a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.... Full company profile.

Industry
Biotechnology
Founded
2007
CEO
David Johnson
Employees
6
Stock Exchange
US OTC
Ticker Symbol
ADYX
Full Company Profile

Financial Performance

In 2018, Adynxx's revenue was $2.22 million, an increase of 9.76% compared to the previous year's $2.02 million. Losses were -$8.42 million, -67.26% less than in 2017.

Financial Statements